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BEHAVIORAL NEUROSCIENCE
expressed in the brain (Boels and Schaller, 2003; Liu et al., 2005a,b). 
Relaxin-3 expression in the brain is confined to the brainstem, and 
is predominantly expressed by neurons in the gray matter of the 
midline dorsal pons, termed the NI (Burazin et al., 2002; Tanaka 
et al., 2005; Ma et al., 2007). Relaxin-3-expressing neurons project 
axons forward to various regions of the forebrain, densely in the 
septum, hippocampus, lateral hypothalamus, and intergeniculate 
leaflet of the thalamus (Tanaka et al., 2005). Several functions 
of relaxin-3 have been suggested by studies using rats and mice, 
including a role in food intake, stress responses, neuroendocrine 
function, and spatial memory (McGowan et al., 2005, 2006; Tanaka 
et al., 2005; Hida et al., 2006; Ma et al., 2009). One evolutionary 
study reported that relaxin-3 orthologs are present in puffer fish 
and zebrafish, but not in any invertebrate or prokaryote, and that 
these orthologs show high homology between different species in 
the mature peptide region (Wilkinson et al., 2005). This finding 
suggests that the function of this protein is highly conserved.
In the present study, to investigate the function of this peptide in 
the whole body, we generated mice carrying a null mutation in the 
relaxin-3 gene and examined them using a range of behavioral tests of 
sensory/motor functions and emotion-related behaviors as relaxin-3 
is widely distributed in the forebrain. These mice grow normally, 
and are fertile. The general appearance of knockout (KO) mice is 
IntroductIon
Relaxin-3/insulin-like peptide7 (INSL7) has been identified as a 
new member of the insulin/relaxin family using human genomic 
databases (Bathgate et al., 2002). The 142 amino acid human pre-
cursor polypeptide sequence is well conserved between human, 
pig, rat, and mouse (Kizawa et al., 2003). Structurally, this precur-
sor polypeptide consists of signal peptides as well as a B-chain, 
C-peptide and A-chain, and contains the RXXXRXXI motif in the 
B-chain (B12–B19 in human) for binding to the relaxin receptor 
(Bullesbach et al., 1992). Like insulin, a mature two-chain peptide 
is produced after removal of the C-peptide and the formation of 
three disulfide bonds between respective cysteine residues of the 
A-chain and B-chain (James et al., 1977). Relaxin and relaxin-3 are 
thought to have different functions. Relaxin plays a role in female 
reproductive organs (Sherwood, 1994). Female mice without func-
tional relaxin gene have difficulties in delivering milk to their pups 
and interpubic ligament does not relax during pregnancy (Zhao 
et al., 1999). On the other hand, the expression of relaxin-3 has been 
found in the brain and testis using reverse transcriptase-polymerase 
chain reaction (RT-PCR; Liu et al., 2003). In addition, relaxin-3 
activates RXFP3, a G-protein-coupled receptor, with highest affin-
ity (0.31 nM), but, to a lesser extent, can bind RXFP1, the receptor 
for relaxin, and RXFP4, the receptor for INSL5, which is poorly 
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doi: 10.3389/fnbeh.2011.00050indistinguishable from that in wild-type mice. However, behavioral 
screening revealed significant differences in the elevated plus maze 
test, with relaxin-3 KO mice exhibiting slight anxiolytic behavior.
MaterIals and Methods
GeneratIon of relaxIn-3 Ko MIce
 To construct a targeting vector, a 5.5-kb DNA fragment containing 
the initial codon of the relaxin-3 gene and a 4.5-kb DNA frag-
ment containing the 3′-flanking region of relaxin-3 were inserted 
into the pKO Scrambler NTKV1901 targeting vector. A linearized 
targeting vector was transfected into embryonic stem (ES) cells 
derived from 129/SvJ mouse strain by electroporation. ES cells were 
selected with G418 (250 μg/ml) and ganciclovir (5 μM), followed 
by colony isolation. A targeted clone was confirmed by Southern 
blot analysis and was injected into C57BL/6N blastocysts to gener-
ate chimeric mice. Male chimeric mice were bred with C57BL/6N 
female mice. Mutant mice were backcrossed at least eight genera-
tions to the C57BL/6N background. Male mice from the sixth and 
eighth generations were screened with two microsatellite markers, 
D8Mit205 and D8Mit248, using the “speed congenics” approach. 
PCR genotyping of the wild-type mice and the targeted allele was 
performed using primers 5′-TAGCAAGGAGATGGTAAAGGTCA 
GGTT-3′, 5′-CAGAGATTCGTGGGCCAAGATGTC-3′, and 
5′-ACGCCGAGTTAACGCCATCAAAAATA-3′.
southern blot analysIs
The lack of relaxin-3 gene was verified by Southern hybridi-
zation of BamHI-digested tail DNA using the Dig-labeled 3′ 
Probe fragment. Synthesis of DIG-labeled probe was performed 
with DIG-High Prime DNA Labeling and Detection Starter 
Kit II (Roche Diagnostics, Mannheim, Germany) according to 
the manufacturer’s instructions. The PCR primer set for probe 
amplification was 5′-GGAGTGCAGCCCAGAAATAGAGC-3′/5′-
AGCTTTTTACGTGGTTCCTGAGACTGA-3′.
IMMunohIstocheMIstry and in situ hybrIdIzatIon
We previously reported the expression of relaxin-3 in the brain at the 
mRNA and peptide levels. Briefly, wild-type and KO type mice were 
deeply anesthetized with sodium pentobarbital i.p. and perfused with 
0.1 M phosphate-buffered saline followed by 4% paraformaldehyde. 
Coronal sections 30 mm thick in the NI were cut with a cryostat. For 
immunohistochemistry, sections were incubated with monoclonal 
anti-relaxin-3 antibody (dilution 1:1000), then with Cy3-labeled 
anti-mouse IgG (dilution 1:750). The specificity of this primary 
antibody has been described elsewhere (Kizawa et al., 2003; Tanaka 
et al., 2005). For in situ hybridization, sections were deproteinized, 
acetylated and hybridized with DIG-labeled riboprobe synthesized 
from full-length mouse relaxin-3 cDNA in hybridization buffer at 
60°C for 12–14 h. After hybridization, sections were washed, and 
relaxin-3 mRNA was visualized with DIG-coloring steps using alka-
line phosphatase-conjugated anti-DIG antibody. These procedures 
have been previously described elsewhere (Tanaka et al., 2005).
anIMals and experIMental desIGn
Relaxin-3 KO mice and wild-type littermates were obtained by 
breeding heterozygote mice. Behavioral tests were performed with 
male mice from this generation, which were 10 weeks old at the 
start of the behavioral studies (n = 20 for both groups). Housing 
conditions included a 12-h light/dark cycle, with lights on at 7:00 
a.m. and access to food and water ad libitum. Behavioral testing 
was performed between 9:00 a.m. and 6:00 p.m. After the tests, all 
apparatus were cleaned with super hypochlorous water to prevent 
bias caused by olfactory cues in the apparatus. All animal experi-
ments, including the production and maintenance protocols, were 
reviewed and approved by the Animal Care and Use Committee 
of the Kyoto Prefectural University of Medicine. Behavioral stud-
ies were performed in accordance with the guidelines for animal 
experimentation of Graduate School of Medicine, Kyoto University. 
The raw data of the behavioral tests have been disclosed in the 
mouse behavioral phenotype database1.
General health and neuroloGIcal screenInG
To compare the physical characteristics of relaxin-3 KO mice and 
wild-type littermates, we first conducted neurological screening as 
previously described (Miyakawa et al., 2001). The righting, whisker 
touch, and ear twitch reflexes were evaluated, and a number of 
physical measures including body weight, body temperature, and 
the presence of whiskers or bald patches were recorded.
neuroMuscular exaMInatIon
Neuromuscular strength was examined using the grip strength and 
wire-hanging tests. The grip strength meter (O’Hara Co., Tokyo, 
Japan) was used to assess forelimb grip strength. Mice were lifted 
and held by their tail so that their forepaws could grasp a wire 
grid. Mice were then gently pulled backward by the tail with their 
posture parallel to the surface of the table until they released the 
grid. The peak force applied by mouse forelimbs was recorded in 
newtons (N). Each mouse was tested three times and the highest 
value measured was used for statistical analysis. In the wire-hanging 
test, mice were placed on a wire mesh, which was then inverted and 
shaken gently, so that the subject gripped the wire. Latency to fall 
was recorded, with a 60-s cut-off time.
lIGht/darK transItIon test
 A light/dark transition test was conducted, as previously described 
(Takao and Miyakawa, 2006). The apparatus used for the light/dark 
transition test comprised a cage (21 cm × 42 cm × 25 cm) divided 
into two sections of equal size by a partition with a door (Ohara 
Co.). One chamber was brightly illuminated (390 lux), whereas the 
other chamber was dark (2 lux). Mice were placed into the dark 
side and allowed to move freely between the two chambers with 
the door open for 10 min. The total number of transitions, time 
spent in each compartment, first latency of movement to light side, 
and distance traveled were recorded automatically, using Image LD 
software (see Image Analysis).
open fIeld test
Locomotor activity was measured using an open field test. Each 
subject was allowed to move freely in the open field apparatus 
(40 cm × 40 cm × 30 cm; AccuScan Instruments, Columbus, OH, 
USA) equipped with photocells (beam spacing 2.5 cm, beam 
 diameter 4 mm, beam frequency 50 cycles/s). Total distance traveled, 
1http://www.mouse-phenotype.org/
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Motor coordination and balance were tested with the rotarod test. 
We performed the rotarod test using an accelerating rotarod (UGO 
Basile Accelerating Rotarod; Ugo Basile, Comerio VA, Italy) by plac-
ing a mouse on a rotating drum (3 cm diameter) and measuring 
the period that each animal was able to maintain its balance on the 
rod, as latency to fall (seconds). The rotarod was accelerated from 
4 to 40 rpm over a 5-min period.
startle response/prepulse InhIbItIon tests
Startle responses and prepulse inhibition (PPI) of startle responses 
were measured using an automatic startle reflex measurement 
system (O’Hara Co.). At the beginning of each test session, a 
mouse was placed in a Plexiglas cylinder, and left undisturbed for 
10 min. The startle stimulus for all trial types was a 40-ms burst 
of broadband white noise, and the startle response was recorded 
during this time period (measuring the response every 1 ms) 
without the prepulse stimulus. The PPI response was recorded 
for 140 ms, beginning with the onset of the prepulse stimulus. 
The background noise level in each chamber was 70 dB. The peak 
startle amplitude recorded during the 140-ms sampling window 
was used as the dependent variable. A test session consisted of six 
trial types (i.e., two types for startle stimulus only trials, and four 
types for PPI trials). The intensity of the startle stimulus was 110 
or 120 dB. The prepulse stimulus was presented 100 ms before 
the startle stimulus, with an intensity of 74 or 78 dB. Four com-
binations of prepulse and startle stimuli were employed (74–110, 
78–110, 74–120, and 78–120). Six blocks of the six trial types were 
presented in pseudorandom order, such that each trial type was 
presented once within a block. The average intertrial interval was 
15 s (range: 10–20 s).
porsolt forced swIM test
The Porsolt forced swim test was conducted as described previously 
(Miyakawa et al., 2001). The apparatus consisted of four Plexiglas 
cylinders (20 cm height × 10 cm diameter). The cylinders were filled 
with water at 23°C, up to a height of 7.5 cm. Mice were placed into 
the cylinders. The duration of immobility and distance traveled 
were recorded over a 10-min test period (days 1 and 2). Images 
were captured at one frame per second. For each pair of succes-
sive frames, the amount of area (pixels) within which the mouse 
moved was measured. When the amount of area was below a cer-
tain threshold, mouse behavior was judged as “immobile.” When 
the amount of area equaled or exceeded the threshold, the mouse 
was considered as “moving.” The optimal threshold by which to 
judge was determined by adjusting it to the amount of immobil-
ity measured by human observation. Immobility lasting for less 
than a 2-s was not included in the analysis. Data acquisition and 
analysis were performed automatically, using Image J based original 
program Image PS software. Data are presented as the percentage 
of immobility time and the distance traveled per each minute of 
the 10-min observation period.
y-Maze test
Exploratory activity was measured using a Y-maze apparatus (arm 
length: 40 cm, arm bottom width: 3 cm, arm upper width: 10 cm, 
height of wall: 12 cm). Each subject was placed in the center of the 
vertical activity (rearing measured by counting the number of pho-
tobeam interruptions), time spent in the center area of the open 
field, and counts of stereotypic behavior were recorded using the 
VersaMax system (AccuScan Instruments, Columbus, OH, USA). 
The center areas were defined as an inner section 1 cm away from 
each of the walls. If the beam at the edge of the open field, 1 cm 
apart from the wall, was not interrupted, mice were considered to 
be in the center area. If a mouse broke the same beam (or set of 
beams) repeatedly, it was considered to exhibit stereotypic activ-
ity. This type of activity is often exhibited as grooming or head 
bobbing behaviors. Stereotypic counts are the number of beam 
breaks that occur during any period of stereotypic activity. Data 
were collected for 120 min.
elevated plus Maze test
Elevated plus maze test was performed as described previously 
(Komada et al., 2008). The elevated plus maze consisted of two 
open arms (25 cm × 5 cm) and two enclosed arms of the same size, 
with 15 cm high transparent walls. The arms and central square 
were constructed from white plastic sheets, elevated to a height of 
55 cm above the floor. To minimize the likelihood of animals fall-
ing from the apparatus, 3-mm high Plexiglas sides were used for 
the open arms. Arms of the same type were arranged at opposite 
sides to each other. This device was set up under low illumination 
(center square 100 lux). Each mouse was placed in the central square 
of the maze (5 cm × 5 cm), facing one of the closed arms. Mouse 
behavior was recorded during a 10-min test period. The number 
of entries into, and the time spent on open and enclosed arms 
were recorded. For data analysis, we employed the following four 
measures: the percentage of entries onto open arms, the stay time 
on open arms (seconds), the number of total entries, and the total 
distance traveled (centimeters). Data acquisition and analysis were 
performed automatically using Image EP software.
hot plate test
The hot plate test was used to evaluate the nociception or the sen-
sitivity to a painful stimulus. Mice were placed on a hot plate at 
55.0 ± 0.3°C (Columbus Instruments, Columbus, OH, USA), and 
the latency to the first hind-paw response was recorded. The hind-
paw responses counted were foot shakes or a paw licks.
socIal InteractIon test In a novel envIronMent
Social interaction test was performed as described previously 
(Yamasaki et al., 2008). Two mice of identical genotypes that 
were previously housed in different cages were placed in a box 
together (40 cm × 40 cm × 30 cm) and allowed to explore freely 
for 10 min. Social behavior was monitored with a CCD camera 
connected to a Macintosh computer, and analysis was performed 
automatically using Image SI software (see Data Analysis). The 
total number of contacts, total duration of active contacts, total 
contact duration, mean duration per contact, and total distance 
traveled were measured. The active contact was defined as fol-
lows. Images were captured at 3 frames per second, and distance 
traveled between two successive frames was calculated for each 
mouse. If the two mice contacted each other and the distance 
traveled by either mouse was longer than 3 cm, the behavior was 
considered an “active contact.”
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In body weight, open field, rotarod, Porsolt forced swim, and fear 
conditioning, data were analyzed using two-way repeated measures 
ANOVA. Alpha level was set to 0.05. Values in tables and graphs are 
presented as mean ± SEM.
results
GeneratIon of relaxIn-3 Ko MIce
To disrupt the relaxin-3 gene, exon 1 and exon 2 were replaced 
with a PGK-neomycin resistance cassette (Figure 1A). After elec-
troporation and double selection with G418 and ganciclovir, ES 
cell lines in which the relaxin-3 locus was correctly targeted were 
identified with Southern blot analysis. We used these lines to gener-
ate chimeric animals. Male chimeras were mated with wild-type 
C57BL/6N females, and their offspring were analyzed for relaxin-3 
recombination using PCR and Southern blotting analysis. After 
eight generations of backcrossing with C57BL/6N, relaxin-3 null 
mice were generated by mating heterozygous mice (Figure 1B). 
In situ hybridization analysis and immunohistochemistry showed 
that the mRNA and peptides of relaxin-3 were never exhibited in 
the NI (Figure 1C).
General health of relaxIn-3 Ko MIce
There were no evident abnormalities in the physical characteris-
tics of relaxin-3 KO mice, including reproductive capability, and 
no significant differences in body temperature, grip strength or 
wire-hanging time between relaxin-3 KO and wild-type litter-
mates (Table 1). The body weight of wild-, hetero- or homozy-
gous relaxin-3 KO mice was also measured once weekly between 
3 and 28 weeks of age (Figure 2). Mean body weight was not dif-
ferent among three genotypes. The life-span of KO and heterozy-
gote mice was at least 18 months, not different from that of wild 
genotype mice.
anxIety-related behavIor In relaxIn-3 Ko MIce
The light/dark transition test, open field test, and elevated plus 
maze were conducted as indices of anxiety-related behavioral phe-
notype (Figures 3–5). In the light/dark transition test, there were 
no significant differences between relaxin-3 KO and wild-type 
mice in the distance traveled (Figure 3A; light: p = 0.555, dark: 
p = 0.825), stay time in the light chamber (Figure 3B; p = 0.671), 
number of transitions between chambers (Figure 3C; p = 0.777), 
or latency to first enter the light chamber (Figure 3D; p = 0.325, 
Mann–Whitney’s U-test). In the open field test, no significant 
differences were observed in the distance traveled (Figure 4A; 
F1,38 = 0.839, p = 0.366) or the counts of stereotypic behavior 
(Figure 4D; F1,38 = 0.01, p = 0.921) among the two genotypes. 
Although vertical activity was slightly increased in relaxin-3 KO 
mice compared with wild-type (Figure 4B; F1,38 = 2.411, p = 0.129), 
significant difference was observed in the vertical activity during 
the first 30 min (F1.38 = 4.134, p = 0.049). There was no significant 
difference between the two groups in the time spent in the central 
area (Figure 4C; F1,38 = 0.278, p = 0.601). Similarly, the major dif-
ferences were not seen in the time spent in the central area during 
the first 10 min (Figure 4E; p = 0.508). On the other hand, the 
elevated plus maze revealed that relaxin-3 KO mice performed a 
significantly higher percentage of entries into the open arms, and 
Y-maze field. The numbers of entries and alterations were recorded 
using a modified version of the Image EP program. Data were col-
lected for 10 min (Tamada et al., 2010).
contextual and cued fear condItIonInG
Contextual and cued fear conditioning was performed as 
described previously (Takao et al., 2010). Each mouse was placed 
in a test chamber (26 cm × 34 cm × 29 cm) within a larger sound-
attenuated chamber (O’Hara Co.), and allowed to explore freely 
for 2 min. A 30-s burst of 60 dB white noise served as the con-
ditioned stimulus (CS). Next, a mild (2 s, 0.5-mA) foot shock, 
which served as the unconditioned stimulus (US), was adminis-
tered immediately after the CS. Two more CS–US pairings were 
presented with a 2-min interstimulus interval (three times). 
Conditioning data were recorded for 8 min. Context testing was 
conducted 24 h after conditioning in the same chamber for 5 min. 
Cued testing with altered context was conducted for 6 min after 
conditioning using a triangular box (35 cm × 35 cm × 40 cm) 
constructed from white opaque Plexiglas, which was located in a 
different room. During the last 3 min, the auditory stimulus was 
presented. Data acquisition, control of stimuli (i.e., tones and 
shocks), and data analysis were performed automatically using 
Image FZ software. Images were captured at 1 frame per second. 
The distance moved by the mouse (in pixels) was measured for 
each pair of successive frames. If this distance was below 20 pixels, 
the behavior was operationally defined as “freezing.” When the 
distance equaled or exceeded the threshold, the behavior was 
defined as “non-freezing.” The optimal threshold (amount of 
pixels) for determining freezing versus non-freezing was cali-
brated by human observation of the behavior. Freezing lasting 
less than 2 s was not included in the analysis.
taIl suspensIon test
The tail suspension test was performed for a 10-min test session 
according to procedures described by (Steru et al., 1985). Mice 
were suspended 30 cm above the floor in a visually isolated area by 
adhesive tape placed ∼1 cm from the tip of the tail. The duration 
of immobility and distance traveled were recorded over a 10-min 
test period. Images were captured as described in Porsolt forced 
swim test section. Data acquisition and analysis were performed 
automatically using Image TS software (see Image Analysis below).
IMaGe analysIs
The software used for the behavioral studies (Image LD, Image EP, 
Image FZ, Image SI, and Image TS) was based on the public domain 
NIH Image program (developed at the U.S. National Institutes of 
Health and available on the Internet at http://rsb.info.nih.gov/nih-
image/) and ImageJ software2, modified for each test by one of the 
authors (TM; available through O’Hara Co.).
statIstIcal analysIs
Statistical analysis was conducted using Stat View (SAS institute, 
Cary, NC, USA). The significance of between two groups was cal-
culated by Student’s t-test, except when there was a significant dif-
ference between the variances of the two groups (F-test), in which 
2http://rsb.info.nih.gov/ij/
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p = 0.984), or the number of entries into the arms (Figure 5A; 
p = 0.758). These results further indicate mildly decreased anxiety-
like behavior in relaxin-3 KO mice.
locoMotor actIvIty In relaxIn-3 Ko MIce
In accord with the lack of a difference in the distance traveled in the 
open field test, the rotarod test revealed no significant differences 
in mean locomotor activity between the two genotypes (Figure 6; 
F1,38 = 2.111, p = 0.155).
socIal InteractIon In relaxIn-3 Ko MIce
In the social interaction test conducted in a novel environment, the 
total duration of contacts (Figure 7A; p = 0.828), mean duration 
per contact (Figure 7D; p = 0.504), total duration of active contacts 
(Figure 7C; p = 0.154), distance traveled (Figure 7E; p = 0.743), 
and mean number of contacts (Figure 7B; p = 0.347) did not differ 
between genotypes.
Figure 1 | relaxin-3 KO mice. (A) Construction of the targeting vector for 
producing relaxin-3 KO mice. The genomic region between exon I and exon II 
of relaxin-3 gene was disrupted by PGK-neomycin resistance cassette. (B) 
Southern blot of BamHI-digested genomic DNA using a 3′ external probe. The 
DNA bands indicated by arrows (12 kb and 5.5 kb) correspond to the 
BamHI-fragments shown in (A). Lanes 1, 2, and 3 are WT (relaxin-3+/+), 
heterozygote (relaxin-3+/−), and KO (relaxin-3−/−), respectively. Note that the 
DNA band in lane 2 is half as intense as that in lane 1 and 3. (C) The expression 
of relaxin-3 was confirmed by immunohistochemistry (left) and in situ 
hybridization (right) of brain sections from wild-type (upper) and relaxin-3 KO 
(lower) mice. Neither relaxin-3 nor mRNA peptide was detected in the nucleus 
incertus (NI) of KO mice.
Table 1 | general health of relaxin-3 KO mice.
Tests Mean  ± SeM  p-Values
  Wild-type  relaxin-3 KO   
 (n = 20)  (n = 20)
Body temperature (°C) 36.70  ± 0.15  37 .00 ± 0.13  p = 0.141
Grip strength (N)  0.84 ± 0.04  0.79 ± 0.03  p = 0.302
Wire-hanging (s)  44.7 ± 4.61  48.2 ± 3.08  p = 0.532
Whisker  n/a    No significance
Coat  n/a    No significance
Reflexes  n/a    No significance
p-Values were calculated by Student’s t-test.
spent a higher percentage of their time in the open arms, indicating 
mildly decreased anxiety-like behavior compared with wild-type 
mice (Figure 5B; p = 0.001, Figure 5D; p = 0.111), although there 
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extensively in humans and animals, and is markedly diminished 
in schizophrenia (Geyer et al., 2002). The startle response to 
acoustic stimulation at 110 and 120 dB was significantly ele-
vated in relaxin-3 KO mice (Figure 8A; 110 dB p = 0.002, 120 dB 
p = 0.037). However, the percent PPI, an index of sensorimo-
tor gating, was greater in relaxin-3 KO than in wild-type mice. 
In particular, a significant difference in PPI between genotypes 
was observed at 78 dB prepulse to 110 dB startle (Figure 8B; 
p = 0.024, Mann–Whitney’s U-test). On the same background of 
startle response (WT_120 dB startle versus KO_110 dB startle), 
the percent PPI of KO mice were significantly elevated by both 
74 dB and 78 dB of prepulse (Figure 8C; 74 dB p = 0.017, 78dB 
p = 0.002, Mann–Whitney’s U-test).
Furthermore, we examined depression-like behavior of 
relaxin-3 KO mice using the Porsolt forced swim test and the 
tail suspension test (Figure 9). The results of the Porsolt forced 
swim test revealed no significant differences in immobility on 
the first (Day 1) and second (Day 2) trial between the mutant 
schIzophrenIa- and depressIon-related characterIstIcs of 
relaxIn-3 Ko MIce
Prepulse inhibition of the acoustic startle response (ASR) is a 
model of sensorimotor gating in which a weak stimulus modi-
fies the behavioral effect of a second, more intense stimulus. 
Figure 3 | Light/dark transition test. Wild-type (n = 19) and relaxin-3 KO 
(n = 20) mice were placed individually in the dark compartment at the start of 
the test. Distance traveled in the light/dark compartments (A), time spent in 
light compartment (B), number of light/dark transitions (C), and latency to enter 
the light compartment (D) were recorded. Data are presented as mean ± SEM. 
p-Values were calculated by Student’s t-test or Mann–Whitney’s U-test.
Figure 2 | Normal growth of relaxin-3 KO mice. The body weight in the 
wild-type (WT), heterozygote (Hete), or KO male and female mice was 
measured during postnatal development. Body weight is presented as 
mean ± SEM. Data were analyzed with repeated measures ANOVA. p-Values 
indicate significance of genotype effect.
Figure 4 | Open field test. Total locomotion distance traveled (A), vertical 
activity (B), time spent in the center of the compartment (C), and stereotypic 
behavior (D) were recorded. Data are presented as mean ± SEM (n = 20 each). 
p-Values indicate significance of genotype effect in two-way repeated 
measures ANOVA. The vertical activity during the first 30 min (bar) was 
statistically significant (p = 0.049). (e) Data of the time spent in the central area 
during the first 10 min were also statistically analyzed using Student’s t-test.
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Contextual and cued fear conditioning test
Both genotypes were assessed with contextual and cued fear con-
ditioning measures on the day after exposure to a footshock paired 
with an auditory-CS. To examine shock sensitivity, we measured the 
and wild-type mice (Figure 9A; F1,38 = 0.658, p = 0.422 and 
F1,38 = 0.747, p = 0.393). In accord with the results of the Porsolt 
forced swim test, no significant difference between genotypes 
was observed in the tail suspension test (Figure 9C; F1,38 = 0.127, 
p = 0.724).
Figure 5 | elevated plus maze test. Mice (n = 20 each) completed the 
elevated plus maze test. The number of arm entries (A), percentage of entry 
into open arms (B), distance traveled (C), and time spent in open arms (D) 
were recorded. Data are presented as mean ± SEM. p-Values were calculated 
by Student’s t-test.
Figure 7 | Social interaction in a novel environment. Total duration of 
contacts (A), number of contacts (B), total duration of active contacts (C), 
mean duration of each contact (D), and total distance traveled (e) were 
recorded. p-Values were calculated by Student’s t-test.
Figure 6 | rotarod test. The rotarod test was performed to measure motor 
function of wild-type (WT) and relaxin-3 KO (KO) mice. The latency to fall from 
an accelerating rotarod was measured in three trials per day. Data are 
presented as mean ± SEM (n = 20 each). p-Values indicate significance of 
genotype effect in two-way repeated measures ANOVA.
Figure 8 | Prepulse inhibition test. Prepulse inhibition was measured by a 
combination of startle (110 or 120 dB) and two prepulse levels (74 and 78 dB) 
in wild-type (n = 20) and relaxin-3 KO (n = 20) mice. Startle responses without 
prepulses (A) and prepulse inhibition of the startle reflex (B,C) were recorded. 
Startle response amplitude and prepulse inhibition are presented as 
mean ± SEM and as the mean percent reduction ± SEM, respectively. 
p-Values were calculated by Student’s t-test or Mann–Whitney’s U-test.
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arm entries (Figure 11A; p = 0.923), in total alternations (Figure 11B; 
p = 0.689), in alternation percentage (Figure 11C; p =  0.284) or in 
total distance (Figure 11D; p = 0.884), indicating that the relaxin-3 
mutation did not affect short-term memory.
dIscussIon
The current results indicated that relaxin-3 KO mice generally 
showed normal development and growth. In addition, KO mice 
did not exhibit any difference in body weight compared with wild-
type or heterozygote mice. Relaxin-3 is known to elicit hyperphagic 
behavior when administered into the cerebral ventricle or hypotha-
lamic nuclei such as the paraventricular (PVN), supraoptic (SON), 
and arcuate nucleus (McGowan et al., 2005, 2007). Two studies have 
examined relaxin-3 KO mice with mixed backgrounds (129S5:B6; 
Smith et al., 2009; Sutton et al., 2009). Sutton et al. (2009) reported 
that KO mice were smaller and leaner than congenic controls. 
However, Smith et al. (2009) reported no significant difference in 
body weight between genotypes. The discrepancy between Sutton 
et al.’s (2009) report and the current findings may have arisen from 
the breeding diet, because the mice in their study were fed on a diet 
with a higher fat content. Our data is in accord with that of Smith 
et al. (2009), suggesting that the absence of relaxin-3 does not affect 
energy consumption and metabolism under normal conditions. 
Not only relaxin-3 KO mice but also mice deficient in other potent 
orexigenic peptides such as neuropeptide Y and ghrelin have also 
been reported to have normal body weight and ad libitum food 
intake (Hollopeter et al., 1998; Sun et al., 2003).
Across a range of behavioral paradigms, KO mice exhibited sig-
nificant differences in tests to assess anxiety and fear. In the elevated 
plus maze, the percentage of entries into the open arms was increased 
in KO mice compared with the wild phenotype. A modified elevated 
plus maze test with closed arms made of transparent walls induces 
moderate stress and is more sensitive to the anxiolytic effects than 
the standard test which presents concurrent states of anxiety and 
fear (Anseloni et al., 1995; Anseloni and Brandao, 1997), suggesting 
that relaxin-3 deficiency would decrease anxiety-related behavior. In 
the open field test, KO mice exhibited an increase in vertical activity, 
indicating increased exploratory behavior, although the time spent 
in the central area was not significantly different. These data indicate 
that relaxin-3 KO mice exhibited mild anxiolytic-like behavior com-
pared with wild genotype mice. This effect might be mediated via 
corticotropin releasing factor (CRF) and its receptor CRF receptor 
type 1 (CRF-R1), both of which are known to play an important role 
in stress response and anxiety (Reul and Holsboer, 2002). CRF-R1-
deficient mice have been reported to exhibit reduced anxiety-related 
behavior, while transgenic mice overexpressing CRF show increased 
anxiety-related behavior (Stenzel-Poore et al., 1994; Smith et al., 1998; 
Timpl et al., 1998). The relaxin-3 receptor, RXFP3 and RXPP1 are 
strongly expressed in the PVN, a major expression site of CRF in the 
hypothalamus, which regulates the hypothalamic–pituitary–adrenal 
axis of stress response (Sutton et al., 2004; Ma et al., 2006; Smith et al., 
2010). We recently demonstrated that intracerebroventricular admin-
istration of relaxin-3 induced c-Fos expression in CRF neurons in 
the PVN and increased plasma corticotropin levels, suggesting that 
relaxin-3 activates CRF neurons (Watanabe et al., 2011). Moreover, 
CRF-expressing neurons are distributed in the central amygdala and 
distance traveled when the footshock was delivered during training. 
Both mutant and wild-type mice responded to footshock (Figure 10F). 
The examination of pain sensitivity by the hot plate test also revealed 
no significant differences in the latency to the first hind-paw response 
between genotypes (Figure 10G; p = 0.418), suggesting normal pain 
sensitivity in relaxin-3f KO mice. In the conditioning phase, there 
was no significant difference in freezing behavior between genotypes 
(Figure 10A; F1,38 = 0.108, p = 0.745). Furthermore, we found no 
significant differences between genotypes in the percentage of time 
spent freezing and travel distance in the contextual and cued tests 
(Figure 10B; F1,38 = 0.517, p = 0.477, Figure 10C; F1,38 = 0.091, p = 0.765, 
Figure 10D; F1,38 = 0.279, p = 0.601, Figure 10E; F1,38 = 1.248, p = 0.271).
Y-maze
Short-term spatial working memory was examined by monitoring 
spontaneous alternation behavior in a Y-maze (Parada-Turska and 
Turski, 1990). There were no significant differences in these  measures 
Figure 9 | Porsolt forced swim test and tail suspension test. The Porsolt 
forced swim test (A,B). Immobility time (A) and total distance traveled (B) 
were recorded in each block for days 1 and 2 (n = 20 each). Tail suspension 
test (C). Data are presented as mean ± SEM. p-Values indicate significance of 
genotype effect in two-way repeated measures ANOVA.
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fibers and RXFP3 are moderately expressed (Swanson et al., 1983; 
Sutton et al., 2004; Tanaka et al., 2005). Taken together, these findings 
suggest that relaxin-3 regulates anxiety-related responses by activating 
CRF–CRF-R1 system. In addition to CRF, other candidate peptides, 
including vasopressin and oxytocin, are thought to be involved in 
anxiety-like behaviors (Rotzinger et al., 2010), possibly mediating the 
effects of relaxin-3, since they exist in neurons of the PVN and SON 
where relaxin-3 receptors (RXFP3 and RXFP1) are strongly expressed 
(Sutton et al., 2004; Ma et al., 2006; Smith et al., 2010).
In the present study, KO mice showed an increased startle 
response to acoustic stimulation and were inclined to exhibit 
greater PPI than wild-type mice. CRF and CRF-R1 are also known 
to influence the ASR and PPI (Risbrough et al., 2004; Sutherland et 
al., 2010). Mice overexpressing CRF have been reported to exhibit 
reduced startle responses and PPI (Dirks et al., 2002). In addition, 
intracerebroventricular infusion of CRF was found to reduce PPI 
in mice and rats (Conti et al., 2002; Risbrough et al., 2004). If the 
CRF response is decreased in relaxin-3 KO mice, ASR and PPI 
might be increased relative to wild-type mice. ASR is mediated 
by an oligosynaptic pathway located in the lower brainstem, and 
its important element is the caudal nucleus of the pontine reticu-
lar formation (Koch and Schnitzler, 1997). Relaxin-3 neurons are 
distributed not only in the NI of the pons but also in the pontine 
raphe nucleus (Tanaka et al., 2005). Therefore, there is a possibility 
that relaxin-3 has a direct effect on ASR.
Figure 10 | Contextual and cued fear conditioning and hot plate test. 
Memory consolidation was assessed with contextual and cued fear conditioning 
tests. Wild-type (n = 20) or relaxin-3 KO (n = 20) mice were placed in a novel 
environment chamber for 8 min, where they received three electrical foot 
shocks. Freezing time (A) and distance traveled (F) were recorded. A tone was 
presented for 30 s (bars) followed by a 2-s foot shock (arrowheads). Twenty-four 
hours later, mice were placed in the same [context; (B,D)] or modified [cue; 
(C,e)] chamber, and freezing time was measured as an indicator of memory 
consolidation. Data are presented as mean ± SEM. p-Values indicate 
significance of genotype effect in two-way repeated measures ANOVA. Pain 
sensitivity was confirmed by the hot plate test (g). Data are presented as 
mean ± SEM. p-Values were calculated by Student’s t-test.
Figure 11 | Y-maze test. Mice (n = 20 each) were individually placed into a 
symmetrical Y-maze. Total number of arm entries (A), number (B) and percentage 
(C) of alternation between Y-maze arms, and total distance (D) were recorded. 
Data presented as mean ± SEM. p-Values were calculated by Student’s t-test.
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studies. Elucidating this question may lead to the development of 
novel drug treatments, such as receptor antagonists for the mitiga-
tion of anxiety responses in humans.
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